Examining the developmental toxicity of piperonyl butoxide as a Sonic hedgehog pathway inhibitor.


Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 20 07 2020
revised: 17 09 2020
accepted: 18 09 2020
pubmed: 3 10 2020
medline: 23 12 2020
entrez: 2 10 2020
Statut: ppublish

Résumé

Piperonyl butoxide (PBO) is a semisynthetic chemical present in hundreds of pesticide formulations used in agricultural, commercial, and residential settings. PBO acts as a pesticide synergist by inhibiting insect cytochrome P450 enzymes and is often present at much higher concentrations than active insecticidal ingredients. PBO was recently discovered to also inhibit Sonic hedgehog (Shh) signaling, a key molecular pathway in embryonic development and in brain and face morphogenesis. Recent animal model studies have shown that in utero PBO exposure can cause overt craniofacial malformations or more subtle neurodevelopmental abnormalities. Related adverse developmental outcomes in humans are etiologically heterogeneous, and, while studies are limited, PBO exposure during pregnancy has been linked to neurodevelopmental deficits. Contextualized in PBO's newly recognized mechanism as a Shh signaling inhibitor, these findings support more rigorous examination of the developmental toxicity of PBO and its potential contribution to etiologically complex human birth defects. In this review, we highlight environmental sources of human PBO exposure and summarize existing animal studies examining the developmental impact of prenatal PBO exposure. Also presented are critical knowledge gaps in our understanding of PBO's pharmacokinetics and potential role in gene-environment and environment-environment interactions that should be addressed to better understand the human health impact of environmental PBO exposure.

Identifiants

pubmed: 33007564
pii: S0045-6535(20)32609-6
doi: 10.1016/j.chemosphere.2020.128414
pmc: PMC9158378
mid: NIHMS1809479
pii:
doi:

Substances chimiques

Hedgehog Proteins 0
Insecticides 0
Pesticides 0
Piperonyl Butoxide LWK91TU9AH

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

128414

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES026819
Pays : United States
Organisme : NIEHS NIH HHS
ID : T32 ES007015
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Toxicol Sci. 2007 Dec;100(2):456-63
pubmed: 17728282
Toxicol Lett. 1994 Apr;71(2):123-9
pubmed: 8171442
Environ Sci Pollut Res Int. 2018 Feb;25(4):3756-3764
pubmed: 29168137
Cancer Res. 2010 Apr 15;70(8):3382-90
pubmed: 20395211
Food Addit Contam. 2003 Mar;20(3):207-14
pubmed: 12623643
Toxicol Lett. 1992 Jan;60(1):83-90
pubmed: 1539185
Toxicol Appl Pharmacol. 1979 Feb;47(2):353-8
pubmed: 452026
Am J Trop Med Hyg. 1952 Sep;1(5):862-83
pubmed: 14952712
Stem Cell Res Ther. 2013;4(6):146
pubmed: 24331293
J Agric Food Chem. 2006 Sep 20;54(19):6957-62
pubmed: 16968048
Proc Soc Exp Biol Med. 1975 May;149(1):302-6
pubmed: 1144444
Birth Defects Res B Dev Reprod Toxicol. 2016 Aug;107(4-5):195-205
pubmed: 27643382
Neurotoxicology. 2017 Jan;58:120-129
pubmed: 27932026
Development. 2003 Nov;130(22):5351-62
pubmed: 13129844
Mol Carcinog. 2010 Mar;49(3):302-14
pubmed: 20025076
Birth Defects Res A Clin Mol Teratol. 2010 Apr;88(4):232-40
pubmed: 20213699
Toxicol Lett. 1993 Aug;69(2):155-61
pubmed: 8212057
Environ Health. 2020 Jun 8;19(1):65
pubmed: 32513280
Am J Med Genet A. 2011 Nov;155A(11):2713-20
pubmed: 21976454
Environ Health Perspect. 2019 Oct;127(10):107006
pubmed: 31642701
Clin Plast Surg. 2014 Apr;41(2):149-63
pubmed: 24607185
Oncol Lett. 2015 May;9(5):2381-2387
pubmed: 26137075
Exp Biol Med (Maywood). 2005 Jun;230(6):366-75
pubmed: 15956766
Int J Cancer. 2012 Jul 1;131(1):30-40
pubmed: 21796625
Teratology. 1990 Aug;42(2):105-19
pubmed: 2218940
Am J Med Genet C Semin Med Genet. 2018 Jun;178(2):122-127
pubmed: 30182446
Drug Metab Dispos. 2013 Feb;41(2):256-62
pubmed: 23328895
Development. 1998 Dec;125(24):5079-89
pubmed: 9811591
Toxicol Sci. 2012 Aug;128(2):517-23
pubmed: 22552772
Am J Med Genet C Semin Med Genet. 2013 Nov;163C(4):246-58
pubmed: 24124047
Cancers (Basel). 2016 Feb 15;8(2):
pubmed: 26891329
Am J Med Genet C Semin Med Genet. 2018 Jun;178(2):165-174
pubmed: 29770992
Genes Dev. 2002 Nov 1;16(21):2743-8
pubmed: 12414725
Environ Sci Technol. 2003 Oct 15;37(20):4543-53
pubmed: 14594359
Interdiscip Toxicol. 2009 Mar;2(1):1-12
pubmed: 21217838
Mol Nutr Food Res. 2018 Jan;62(1):
pubmed: 29164817
CNS Neurosci Ther. 2013 Dec;19(12):926-36
pubmed: 24165291
PLoS One. 2015 Mar 20;10(3):e0120517
pubmed: 25793997
Toxicol Ind Health. 1995 Mar-Apr;11(2):175-84
pubmed: 7491633
PLoS One. 2012;7(9):e46083
pubmed: 23029396
Development. 2020 Jul 17;147(21):
pubmed: 32680836
Wiley Interdiscip Rev Dev Biol. 2017 Jan;6(1):
pubmed: 27626243
Toxins (Basel). 2020 Feb 12;12(2):
pubmed: 32059484
Science. 1947 May 16;105(2733):530-1
pubmed: 17794097
F1000Res. 2016 Nov 30;5:2800
pubmed: 27990279
Am J Med Genet C Semin Med Genet. 2018 Jun;178(2):140-150
pubmed: 29749693
Biochem Pharmacol. 1970 Jan;19(1):91-112
pubmed: 4396245
J Urol. 2012 Dec;188(6):2354-60
pubmed: 23088992
Chembiochem. 2008 May 5;9(7):1082-92
pubmed: 18357592
J Med Genet. 2012 Jul;49(7):473-9
pubmed: 22791840
Nat Prod Rep. 2016 May 4;33(5):595-601
pubmed: 26787175
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3415-20
pubmed: 25733905
Toxicol Ind Health. 2019 Apr;35(4):314-323
pubmed: 30871449
Development. 2009 Dec;136(23):3949-57
pubmed: 19906862
Food Cosmet Toxicol. 1977 Aug;15(4):337-9
pubmed: 590894
PLoS One. 2013 Dec 10;8(12):e82562
pubmed: 24340040
Ecotoxicol Environ Saf. 1978 Jun;2(1):9-31
pubmed: 398254
Food Chem Toxicol. 1992 Dec;30(12):1015-9
pubmed: 1473795
Development. 2005 Nov;132(22):4987-98
pubmed: 16221724
Arch Environ Health. 1972 Feb;24(2):97-106
pubmed: 5007655
Phytother Res. 2017 Apr;31(4):680-688
pubmed: 28198062
Toxicol Appl Pharmacol. 2016 Jun 1;300:34-46
pubmed: 27058323
Curr Top Dev Biol. 2016;116:569-80
pubmed: 26970642
Toxicol Lett. 1999 Jun 30;107(1-3):207-17
pubmed: 10414798
Molecules. 2016 Oct 14;21(10):
pubmed: 27754442
Cells. 2018 Dec 14;7(12):
pubmed: 30558232
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):12907-12
pubmed: 20615943
Am J Med Genet C Semin Med Genet. 2010 Feb 15;154C(1):158-69
pubmed: 20104613
Nature. 1996 Oct 3;383(6599):407-13
pubmed: 8837770
Wiley Interdiscip Rev Dev Biol. 2015 Jan-Feb;4(1):17-32
pubmed: 25339593
Pediatrics. 2011 Mar;127(3):e699-706
pubmed: 21300677
Xenobiotica. 2006 Dec;36(12):1259-72
pubmed: 17162471
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3131-3140
pubmed: 30177379
Nat Rev Genet. 2011 Mar;12(3):167-78
pubmed: 21331089
Mol Cell Biochem. 2013 Jan;373(1-2):217-27
pubmed: 23129257
Birth Defects Res B Dev Reprod Toxicol. 2015 Dec;104(6):227-37
pubmed: 26431353

Auteurs

Kenneth S Rivera-González (KS)

Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, 53706, USA; Molecular and Environmental Toxicology Graduate Training Program, University of Wisconsin-Madison, Madison, WI, 53706, USA.

Tyler G Beames (TG)

Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, 53706, USA; Molecular and Environmental Toxicology Graduate Training Program, University of Wisconsin-Madison, Madison, WI, 53706, USA.

Robert J Lipinski (RJ)

Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, 53706, USA; Molecular and Environmental Toxicology Graduate Training Program, University of Wisconsin-Madison, Madison, WI, 53706, USA. Electronic address: robert.lipinski@wisc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH